Deletions of the distal short arm of chromosome 1 Deletion of the distal band(s) of some chromosomes (1p36) represent a common, newly delineated deletion has long been recognized as the cause of certain gesyndrome, characterized by moderate to severe psychonetic disorders with congenital abnormalities and motor retardation, seizures, growth delay, and dysmor-mental retardation; examples include Wolf-Hirschphic features. Previous cytogenetic underascertainment horn syndrome (4p monosomy) (Wolf et al. 1965 ; of this chromosomal deletion has made it difficult to Leao et al. 1967 ) and cri-du-chat syndrome (5p monocharacterize the clinical and molecular aspects of the somy) (Lejeune et al. 1963) , although, by high-resolusyndrome. Recent advances in cytogenetic technology, tion chromosomal banding techniques, distal deleparticularly FISH, have greatly improved the ability to tions for virtually all chromosomes have been identify 1p36 deletions and have allowed a clearer defiidentified in patients. Deletion of the distal short arm nition of the clinical phenotype and molecular character-of chromosome 1 (1p36 deletion) is a recently identiistics of this syndrome. We have identified 14 patients fied chromosomal syndrome that we believe has been with chromosome 1p36 deletions and have assessed the previously underascertained by cytogenetic analysis. frequency of each phenotypic feature and clinical mani-This may be due to the difficulty in clearly visualizing festation in the 13 patients with pure 1p36 deletions.
Texas Medical School) were identified as having 1p36 deletions, by G-banded chromosome analysis per- Keppler-Noreuil et al. 1995; Reish et al. 1995; Sandlin et al. 1995) .
formed on peripheral blood lymphocytes; 1 additional patient was ascertained prenatally, by chromosome In delineating the clinical features of 1p36 deletions, previous clinical summaries have not confined their analysis performed on amniocytes, and was confirmed postnatally, by analysis of peripheral blood lymphocharacterization of the deletion phenotype to patients with pure 1p36 deletions (Keppler-Noreuil et al. cytes, to have a 1p36 deletion. Blood samples were subsequently collected from all 14 patients and their 1995; Reish et al. 1995; Sandlin et al. 1995) ; they have included the phenotypic features and clinical available parents, and lymphoblastoid cell lines were established by methods described elsewhere (Watt and manifestations of patients with double-segmental imbalances. This approach may provide a general gestalt
Stephen 1986). The protocols were approved by the institutional review board of Baylor College of Mediof the physical features and medical problems associated with 1p36 deletions; however, assessment of the cine, and informed consent was obtained from the parents or guardians of all patients. frequency of each particular phenotypic feature and definition of the isolated 1p36 deletion phenotype Thorough clinical characterization of the patients was performed after the cytogenetic diagnosis was eshave been confounded by the effects of other chromosomal imbalance.
tablished, in order to document features for table 1; all of the features listed within table 1 were part of a Herein we describe the clinical features of 13 patients with isolated deletion of the distal short arm of checklist utilized by the examiner. The checklist was compiled on the basis of features reported previously chromosome 1. In order to define the clinical phenotype of patients with this chromosomal deletion synin the literature, as well as on the basis of features observed in our patients. All patients presented in this drome, we compare the phenotypes of our patients with those of four patients previously described with report were examined by one of the authors (patients 2 -14 were examined by S.K.S., and patient 1 was presumedly pure 1p36 deletions (Keppler-Noreuil et al. 1995; Reish et al. 1995) and with that of one paexamined by F.G.). Eight of the 14 patients have been examined (by S.K.S.) on more than one occasion, in tient with a 1p35 deletion (Wenger et al. 1988) . By excluding the patients with double-segmental imbalorder to document any changes in their features. ance, we can assess the variability of features that FISH appear specific to patients with the 1p36 deletion.
It has been suggested that the phenotypic variability Metaphase chromosome preparations of peripheral blood lymphocytes from the 14 patients and available among patients with the 1p36 deletion syndrome, particularly with regard to growth, may be due to the parents were studied by FISH using four probes mapping to 1p36.3: p1-79 (ATCC), p58 (Oncor), 1A9, and parental origin of the deletion and to the effects of imprinted genes Keppler-13P11 . A FISH probe mapping to the centromere of chromosome 1, D1Z5 (Oncor), was used as a control. Noreuil et al. 1995) . Conversely, phenotypic variability may be due to submicroscopic differences in the Probe p1-79 (also known as ''D1Z2'') binds to a distal 1p hypervariable repeated sequence (Buroker et al. physical extent of each deletion resulting in the loss of different contiguous dosage-sensitive genes, or due 1987). Probe p58 (also known as ''CDC2L1'' or ''PITSLRE'') identifies a cell cycle-regulated kinase gene to the unmasking of certain recessive alleles. In order to investigate these possibilities, our 13 patients with with homology to human CDC2 (Bunnell et al. 1990 ). BAC probe 1A9 (Shizuya et al. 1992 ) and PAC probe pure 1p36 deletions, as well as 1 patient with distal 1p monosomy in conjunction with minimal distal 22q 13P11 (Ning et al. 1996) are clones of chromosome 1-specific sequences that contain the DNA polymortrisomy, have been studied with DNA polymorphisms and FISH, to determine the parental origin of each phisms D1S214 and D1S1615, respectively. All FISH analyses were performed according to methods dedeleted chromosome, as well as to define the extent of each deletion interval. The results indicate that no scribed elsewhere (Shaffer et al. 1994 ). parent-of-origin effect is obvious and that the physical Polymorphic Marker Analysis extent of deletions of 1p36 is quite variable.
Total cellular DNA was prepared from either peripheral blood lymphocytes or lymphoblastoid cell Subjects, Material, and Methods lines (Spence et al. 1987) . As many as 12 dinucleotide Patients and Cell Lines or tetranucleotide polymorphisms located in chromosome 1p36 were analyzed on the 14 patients and their During 1993 -96, 13 patients referred, for cytogenetic studies, to the Kleberg Cytogenetics Laboratory available parents (Shaffer et al. 1993 NOTE.-Data are proportion or percentage of patients in whom the feature either could be directly assessed or was specifically noted in a clinical report.
a Includes hand biting, banging or throwing objects, striking people, and episodes of violent physical activity.
b Includes simple and complex partial seizures, myoclonus, and infantile spasms (modified hypsarrhythmia).
c Includes lateral ventricle asymmetry, ventricular enlargement, and focal atrophy.
(except patient 3, in whom heterozygosity for a Web (1997) resources (http://www.med.upenn.edu/ Çponcol/chr1/resources.html) and from radiationmarker was used to indicate lack of deletion). The marker order on the genetic map was based on maphybrid mapping data for 1p35-36 (Jensen et al., 1997 figure 2A . Cytogenetic studies of the mothers (n Å 14) and available fathers (n Å 9), in conjunction with FISH using probes p1-79 and p58, showed no rearrangements involving distal 1p for the parents of 13 of the 14 patients. The one exception was the father of patient 13, who was found to carry a presumed balanced translocation with breakpoints in 1p36.2 and 22q13.3. Metaphase cells from the 14 patients with 1p36 deletions were analyzed by FISH using probes p1-79, p58, 1A9, and 13P11; a representative example of the FISH analysis for 1 patient is shown in figure 2B . All 14 patients were deleted for probe p58, 13 of 14 patients were deleted for probe p1-79, 5 of 14 patients were deleted for probe 1A9, and 2 of 14 patients were deleted for probe 13P11 (results are summarized in fig. 3 ). Patient 4 (not deleted for p1-79) is presumed to have an interstitial deletion, within 1p36.3, that preserves the more telomeric region of the chromosome (containing p1-79) but that still deletes the region containing p58. These results from patient 4 suggest that p1-79 is distal to p58 on chromosome 1. served with 17% paternally derived and 83% maternally ure 1. Patient 13 has a presumed double-segmental im-derived deletions (x 2 1 Å 5.3, .01 õ P õ .05). On the balance (1p36 monosomy and minimal 22q13.3 tri-basis of the polymorphic marker and FISH results, the somy) and is not included in the clinical characterization size of the deletion region was found to vary between of pure 1p36 deletions. The frequencies of clinical fea-the patients. By combining the FISH analyses using tures of the remaining 13 patients are listed in table 1, probes p1-79, p58, 1A9, and 13P11 with the polymoralong with data from reports describing 5 other patients phic marker analyses, the deletions could be arrayed, with similar single-segmental imbalances: 4 individuals with many patients having deletions of different size but with 1p36 deletions (Keppler-Noreuil et al. 1995 ; Reish all of them containing a minimal deletion interval, in et al. 1995) and 1 individual with a 1p35 deletion distal 1p36, that encompassed marker D1S243 and (Wenger et al. 1988) . Patients with pure 1p36 deletions probe p58 ( fig. 3) . On the basis of the markers used in reported by others in abstracts alone (Magenis et al. the present study, patient 4 appeared to have the small-1987; Wexler et al. 1991 ; est deletion, and patient 13 had the largest deletion. Sandlin et al. 1995) were not included in this comparison, because of lack of a complete phenotypic descripDiscussion tion and photographs.
Molecular Polymorphism Analysis of 1p36 Deletion
Thirteen patients with pure chromosome 1p36 deleCytogenetic and FISH Analyses of 1p36 Deletion tions have been evaluated for their clinical phenotypes Syndrome Patients (table 1) . These 13 patients with single-segmental imbalance, as well as 1 patient with a double-segmental imbalThe 1p36 deletions in the 14 patients were ascertained by 600-800-band-resolution cytogenetic analysis, and ance (patient 13), have been evaluated for the size and / 9a35$$se33 08-29-97 09:26:26 ajhgal UC-AJHG parental origin of their deletions ( fig. 3 ). Cytogenetic segmental imbalance. Although the fathers of five of the patients were not available for testing by cytogenetic and molecular studies have determined that, in the 13 patients with pure 1p36 deletions, the deletions are de analysis or FISH in order to exclude a paternal translocation, in each of these cases the origin of the deleted novo and do not appear to include other chromosomal chromosome was found, by molecular studies, to be maternal, thus confirming that each deletion was a de novo event. The patients reported here represent a useful resource for delineation of the clinical phenotype, because they represent a substantial cohort of pure singlesegmental imbalance for 1p36 deletions. Patient 13 (with presumed double-segmental imbalance), who was excluded from the clinical characterization of the syndrome (table 1) but was included in the molecular studies ( fig. 3) , is of interest because, by cytogenetic and FISH analysis, he appeared to have a pure 1p36 deletion. However, only after the cytogenetic and FISH studies performed on his parents identified his father as a translocation carrier was the cytogenetic interpretation for him changed to 46,XY,der(1)t(1;22)(p36.2;q13.3)pat. Therefore, it is prudent to perform cytogenetic and FISH evaluation of the parents of all 1p36 deletion patients, in order to exclude the possibility that a patient has an unbalanced-translocation product inherited from a parent who carries a balanced translocation. The 1p36 deletion syndrome appears to be more common than most other deletion syndromes. Population studies have shown that, for other deletion syndromes, the incidence is estimated to be 1/45,000 for 5p monosomy (Niebuhr 1978), 1/25,000 for Prader-Willi syndrome (Butler 1990) , and §1/4,000 for the 22q11 dele- (M) . Since parental samples were not available for the analysis of patient 3, the indicated deleted regions were determined by analysis with FISH probes, and the nondeleted regions were inferred from heterozygosity for the microsatellite markers.
in the catchment area have yet been ascertained. This estimate may seem high, but 1p36 deletions are likely being underascertained in most cytogenetics laboratories. Of our 14 patients, 6 had prior cytogenetic studies in which the deletion was not identified. Three of these six patients had their initial cytogenetic study performed in 1996 (one in each of three different cytogenetics laboratories), and two of these three patients (13 and 14) have large deletions that were not detected in the initial cytogenetic studies.
For individuals with monosomy for 1p36, moderate to severe mental retardation, hypotonia, and developmental delay are found almost universally. Full-scale IQ scores are generally õ60 (on the basis of testing performed on our six oldest patients; the other patients were too young for adequate testing). Although gross and fine motor skills are moderately delayed, speech Figure 4 Polymorphic marker analysis for 1p36 deletion padevelopment is more significantly impaired. The vast tients. Fully informative analyses of two chromosome 1p36 markers majority (85%) of individuals have significant growth are shown for patients 8 and 9 and their parents. Patient 9 demonretardation. However, several reports note that a few strates inheritance of only one allele (from her father) for marker individuals had infantile feeding problems and poor D1S468 and therefore has a deletion for this marker on the maternally weight gain but developed obesity and/or macrosomia derived chromosome. At locus D1S548, patient 9 is heterozygous, since she has inherited a different allele from each parent, indicating in childhood, like patients with Prader-Willi syndrome no deletion for this marker. Patient 8 has a deletion on the paternally (Wenger et al. 1988; Keppler- derived chromosome, since she has inherited only one allele (from her Noreuil et al. 1995) ; in each of these cases, the diagnosis mother) for marker D1S243. Patient 8 is heterozygous for the marker of Prader-Willi syndrome was suggested before the cor- 1995; Sandlin et al. 1995) have sugalso suggested that congenital heart defects and cardiomyopathy are common features of this deletion syngested that two distinct clinical phenotypes constitute this deletion syndrome: (1) growth failure associated drome, but we did not find congenital heart defects to be common in our cohort. Two of our patients (patients with hirsutism, specific craniofacial features (small face, midface hypoplasia, short up-slanting palpebral fissures, 12 and 14) had infantile cardiomyopathy, and none of our patients had significant congenital heart defects (one epicanthal folds, deep-set eyes, small nose, and micrognathia), and cleft lip and/or cleft palate and (2) normal had a patent ductus arteriosus, and one had mild leftpulmonary-artery-branch stenosis). Other reports have growth parameters or obesity associated with other craniofacial features (tall forehead, broad face, bitemporal described patients with infundibular stenosis, tetralogy of Fallot, and ventricular septal defects (Yunis et al. narrowing, normal palpebral fissures, hypertelorism, sparse eyebrows, flat nasal bridge, broad nasal root, and 1981; Magenis et al. 1987; Biegel et al. 1993 ), but in the first case there was other chromosomal segmental prominent jaw or prognathism). Our experience, based on detailed clinical assessment of the 14 patients re-imbalance, and in the other two cases the deletion breakpoints were judged to be more proximal (1p36.13 ported here, is that each of the craniofacial features of these two supposed clinical phenotypes occurs in a proand 1p36.1, respectively) than those in the patients described here. Therefore, we do not consider significant portion of the patients but that these features do not separate the patients into two distinguishable groups. In cardiac defects to be a common feature of this deletion syndrome. However, infantile cardiomyopathy occurred addition, it does not appear that differing craniofacial features are due to the size of the chromosomal deletion.
in two of our patients, as well as in two other patients with pure 1p36 deletions (Keppler-Noreuil et al. 1995) , Patients with both small and large deletions may have very similar craniofacial features (compare patients 4 and may occur in £44% of patients.
It has been suggested that cleft lip or cleft lip/palate and 9 [ fig. 1 ], who have developed a closer resemblance as patient 9 has grown older), whereas patients with occurs in £40% of patients with this condition (Keppler-Noreuil et al. 1995) . Two of our patients had similar-size deletions may have quite different phenotypes (compare patients 1 and 2 [ fig. 1 ], whose photo-clefting defects (patient 14 had cleft lip, and patient 12 had cleft lip/palate), which suggests a lower incidence graphs were obtained at the same age). The phenotypic variability among these patients may represent ethnic (closer to 10%) for this congenital anomaly.
Although there is clinical variability between the padifferences, may reflect natural variation in the genetic background, or may be associated with deletion of spetients with the 1p36 deletion syndrome, this condition has a recognizable phenotype that is unique enough to cific regions of the genetic map.
At birth, all of our patients had normal measurements consider it as a newly delineated syndrome; in our patient series, the diagnosis was made by the geneticist for weight, length, and head circumference, but the vast majority (85%) became growth retarded at age ú1 year.
and/or neurologist, on the basis of clinical examination, before the cytogenetic result was available, for Several older patients had normal growth parameters at the time of ascertainment (in our series, patients 2 and patients 11 -14; the other 10 patients were diagnosed retrospectively after chromosome analysis (except for 11), and a few patients had infantile feeding problems but developed childhood obesity similar to what occurs patient 8, who was diagnosed by prenatal testing). The prospective diagnosis for patients 11 -14 was possible in Prader-Willi syndrome (in our series, patient 4). The two older patients with normal growth parameters at because each patient had many of the most common features listed in table 1, as well as having had some the time of ascertainment (both of whom were girls 10-11 years of age) previously had been õ3d centile for of the other less common features (i.e., cleft lip/palate, infantile cardiomyopathy, and infant feeding probheight and weight but subsequently had early pubertal growth spurts that increased their height and weight to lems). On the basis of the clinical assessments of our entire patient cohort and those reviewed in the literathe normal range. As these two patients are followed, it is expected that they will complete puberty early (they ture who have single-segmental imbalance, we suggest that the most common features that constitute this deleare already Tanner IV-V at age 10-11 years and started menses at age 10 years), plateau in their growth, and tion syndrome include large anterior fontanelle (100%), motor delay/hypotonia (92%), moderate to attain adult heights that are õ3d centile. Thus, the category of patients with ''normal growth'' or obesity may in severe mental retardation (92%), growth delay (85%), pointed chin (80%), eye/vision problems (75%), seifact represent hypothalamic/pituitary dysfunction that manifests as precocious puberty in some patients and zures (72%), flat nasal bridge (65%), clinodactyly and/ or short fifth finger(s) (64%), low-set ear(s) (59%), ear as obesity in others. We did not observe a correlation between these growth anomalies and particular cranio-asymmetry (57%), hearing deficits (56%), abusive behavior (56%), thickened ear helices (53%), and deepfacial features, as has been suggested in other reports (Keppler-Noreuil et al. 1995) .
set eyes (50% seizures, but these patients have abnormal EEGs and require anticonvulsants for treatment of chronic seizures (in our series, patients 5, 9, and 11 -14).
